New drug trial offers hope for muscle weakness sufferers
NCT ID NCT07215650
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 29 times
Summary
This study is testing a new medicine called cizutamig in people with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. The main goal is to check if the drug is safe and how the body processes it. About 44 adults with moderate to severe symptoms who haven't responded well to standard treatments will take part. This is an early-stage trial, so it focuses on safety and finding the right dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huashan Hospital Affiliated to Fudan University
RECRUITINGShanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.